Beverley Hunt

Last updated
Beverley Hunt
OBE FRCP FRCPath
Beverley Hunt.jpg
Born
Beverley Jane Hunt
Education University of Liverpool
OccupationsPhysician, academic
Known forResearch on venous thromboembolism and thrombosis prevention
Awards Officer of the Order of the British Empire (2019)
Medical career
FieldHaematology; thrombosis; haemostasis
Institutions King's College London
Guy's and St Thomas' NHS Foundation Trust

Beverley Jane Hunt OBE FRCP FRCPath is a British haematologist. She is an honorary professor of thrombosis and haemostasis at King's College London and a consultant in thrombosis and haemostasis at Guy's and St Thomas' NHS Foundation Trust. [1] [2] Her research concerns thrombosis, haemostasis, venous thromboembolism (VTE), antiphospholipid syndrome, and obstetric haematology. She co-founded Thrombosis UK and serves as co-chair of its board of trustees.

Contents

Education

Hunt was educated at Walthamstow Hall. [3] She studied medicine at the University of Liverpool, graduating with an MB ChB degree in 1979. She later completed a MD degree at the University of Liverpool in 1997; her thesis concerned haemostasis and accelerated coronary artery disease in cardiac transplant recipients. [4]

She became a Fellow of the Royal College of Physicians in 1996 and a Fellow of the Royal College of Pathologists in 1997. [5]

Career

Hunt became a consultant in the departments of haematology and pathology at Guy's and St Thomas' NHS Foundation Trust [6] in 1991. She has directed its Thrombosis and Haemostasis Research Laboratory [7] and has chaired the trust's Thrombosis and thromboprophylaxis Committee since 2008. [8]

In 2008, Hunt was appointed Professor of Thrombosis and Haemostasis at King's College London. [9] In 2023, she was appointed visiting professor of haematology at Nara University in Japan. [10]

Thrombosis UK

In 2002, Hunt co-founded the charity that became Thrombosis UK. The organisation promotes awareness, prevention, and treatment of thrombosis and provides information and support to people affected by VTE and their families. Hunt served as its medical director before becoming co-chair of its board of trustees. [11]

Specialist interest and research

Hunt's research focuses on the prevention, diagnosis, and treatment of thrombosis and acquired bleeding disorders. Her work on venous thromboembolism (VTE) has included hospital-associated thrombosis, risk assessment, and the use of thromboprophylaxis in medical and surgical patients. [12] [13]

A substantial part of her research concerns thrombosis during pregnancy and the postpartum period. She has studied VTE risk assessment and prevention in pregnancy, anticoagulant use, and pregnancy complications associated with antiphospholipid syndrome and inherited thrombophilia. [14] [15] Her work has also addressed the management of antithrombin deficiency and other disorders of physiological anticoagulants. [16]

Hunt has conducted research on haemostatic disorders in critical care, surgery, trauma, and extracorporeal circulation. This has included work on major haemorrhage, cardiopulmonary bypass, extracorporeal membrane oxygenation, fibrinolysis, coagulation testing, and anticoagulant and procoagulant therapies. [17] [18] [19]

During the COVID-19 pandemic, Hunt contributed to research on COVID-19-associated coagulopathy, anticoagulation, and thrombotic complications in hospitalised patients. [20] [21] She was a member of the UK Expert Haematology Panel that described vaccine-induced immune thrombotic thrombocytopenia and developed clinical guidance for the condition. [22] [23]

In 2025, Hunt became a co-chair of the VTE working group for Element 1 of NHS England's Maternal Care Bundle. Published in January 2026, the element included an early-pregnancy VTE risk-assessment tool for use by patients and healthcare professionals. [24] [1]

Her other publications have addressed cancer-associated thrombosis, cerebrovascular disease in antiphospholipid syndrome, cardiovascular risk in haemophilia, kidney transplantation, and strategies for preventing post-thrombotic syndrome. [25] [26] [27] [28]

Contribution to national and international guidelines

Hunt has contributed to guidelines and consensus reports on primary immune thrombocytopenia, heritable thrombophilia, thrombocytosis, and the management of major bleeding following trauma. [29] [30] [31] [32]

She served on National Institute for Health and Care Excellence groups that developed guidance on the prevention and management of VTE and a quality standard for VTE prevention. [33] [34] During the COVID-19 pandemic, she was a member of NICE's expert advisory panel for its managing COVID-19 rapid guideline. [35] From 2022, she co-chaired the World Health Organization group responsible for its living COVID-19 management guideline. [36]

Within the International Society on Thrombosis and Haemostasis (ISTH), Hunt chaired the local organising committee for the society's 2022 congress in London [37] and later co-chaired its Scientific and Standardization Committee Subcommittee on Physiological Anticoagulants and Thrombophilia. [38]

Society memberships

Hunt co-founded the Obstetric Haematology Group of the British Society for Haematology in 2004 and co-chaired it for 15 years. [39] She was also a founding member of the society's Education Committee. [40]

She also serves on the board of the Pulmonary Embolism Response Team Consortium. [41]

Hunt was a founding member of the World Thrombosis Day steering committee in 2014 and served as its chair from 2019 to 2022. [42] [43]

She was elected to the ISTH Council in 2026. [44]

Other interests

Sport

Hunt has competed as an age-group triathlete. She placed third in the women's 55–59 sprint event at the 2010 European Triathlon Championships in Athlone, Ireland. [45]

Writing & theatre

Hunt wrote a play that won a prize in a European playwriting competition. It later received a rehearsed reading featuring actors Greg Wise and Janie Dee. [46]

During the COVID-19 pandemic, Hunt described the effects of severe COVID-19 as "almost medieval", a phrase quoted in David Hare's 2020 monologue Beat the Devil . [47] The monologue was performed by Ralph Fiennes in a production directed by Nicholas Hytner at the Bridge Theatre and was later screened on Sky Arts. [48]

Honours and awards

Books

References

  1. 1 2 3 "Professor Beverley Hunt OBE, FRCP, FRCPath, MD". King's College London. Retrieved 26 August 2026.
  2. 1 2 3 "Beverley Hunt". Guy's and St Thomas' NHS Foundation Trust. Retrieved 26 August 2026.
  3. ↑ "Alumnae Profiles". Walthamstow Hall. 2011-05-29. Archived from the original on 2011-04-24. Retrieved 2012-07-18.
  4. ↑ Frost, Nicola (19 December 2019). "Liverpool alumni and staff take on Christmas University Challenge - University of Liverpool News". Liverpool.ac.uk.
  5. ↑ "Advances in Transfusion Medicine Symposium" (PDF). Royal College of Pathologists. 23 November 2022. p. 1. Retrieved 7 July 2026.
  6. ↑ "Beverley Hunt". Guy's and St Thomas' NHS Foundation Trust.
  7. ↑ "Professor Beverley Hunt is honoured by the Queen". Guy's and St Thomas' NHS Foundation Trust. 10 June 2019.
  8. ↑ "Personal Statement for Award year 2012" (PDF). Advisory Committee on Clinical Excellence Awards. 2012. p. 279.
  9. ↑ "Beverly Hunt". King's College London. Retrieved 7 July 2026.
  10. ↑ "国際交流センターだより vol.17" [International Exchange Center Newsletter, vol. 17](PDF) (in Japanese). Nara Medical University. p. 8. Retrieved 7 July 2026.
  11. ↑ "History". Thrombosis UK. 23 April 2024. Retrieved 26 August 2026.
  12. ↑ Roberts, Lara N.; Arya, Roopen; Hunt, Beverley J. (2024). "Advances and current research in primary thromboprophylaxis to prevent hospital-associated venous thromboembolism". British Journal of Haematology. 204 (5): 1635–1648. doi:10.1111/bjh.19424.
  13. ↑ Horner, Daniel E.; Davis, Sarah; Pandor, Abdulla; et al. (2024). "Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis". Health Technology Assessment. 28 (20): 1–166. doi:10.3310/AWTW6200.
  14. ↑ Davis, Sarah; Pandor, Abdulla; Sampson, Fiona C.; et al. (2024). "Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research". Health Technology Assessment. 28 (9): 1–176.
  15. ↑ Pandor, Abdulla; Daru, Jamal; Hunt, Beverley J.; et al. (2022). "Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review". BMJ Open. 12 (10) e065892. doi: 10.1136/bmjopen-2022-065892 .
  16. ↑ Dix, Caroline; Doyle, Andrew J.; Breen, Karen A.; Hunt, Beverley J. (2025). "The efficacy and safety of direct oral anticoagulants in inherited antithrombin deficiency: a cohort study from a tertiary referral center". Thrombosis and Haemostasis. 125 (4): 379–384. doi:10.1055/a-2379-7288.
  17. ↑ Doyle, Andrew J.; Hunt, Beverley J. (2018). "Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components". Frontiers in Medicine. 5: 352. doi: 10.3389/fmed.2018.00352 .
  18. ↑ Stanworth, Simon J.; Dowling, Kirsty; Curry, Nicola; et al. (2022). "Haematological management of major haemorrhage: a British Society for Haematology guideline". British Journal of Haematology. 198 (4): 654–667.
  19. ↑ Doyle, Andrew J.; Retter, Andrew; Parmar, Kiran; et al. (2025). "Temporal changes in markers of coagulation and fibrinolysis in adults during extracorporeal membrane oxygenation". Perfusion. 40 (4): 984–992.
  20. ↑ Desborough, Michael J. R.; Doyle, Andrew J.; Griffiths, Anna; et al. (2020). "Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom". Thrombosis Research. 193: 1–4. doi: 10.1016/j.thromres.2020.05.049 .
  21. ↑ Godoy, Lucas C.; Neal, Matthew D.; Goligher, Ewan C.; et al. (2024). "Heparin dose intensity and organ support-free days in patients hospitalized for COVID-19". JACC: Advances. 3 (3): 100780.
  22. ↑ Pavord, Sue; Scully, Marie; Hunt, Beverley J.; et al. (2021). "Clinical features of vaccine-induced immune thrombocytopenia and thrombosis". The New England Journal of Medicine. 385 (18): 1680–1689. doi:10.1056/NEJMoa2109908. PMC   10662971 . PMID   34379914.
  23. 1 2 "Celebrating the RCPath Achievement Award Team Winners 2022". Royal College of Pathologists. 20 September 2022. Retrieved 26 August 2026.
  24. ↑ "The Maternal Care Bundle". NHS England. 6 January 2026. Retrieved 26 August 2026.
  25. ↑ Potere, Nicola; Barco, Stefano; Mahé, Isabelle; et al. (2022). "Awareness of venous thromboembolism among patients with cancer: preliminary findings from a global initiative for World Thrombosis Day". Journal of Thrombosis and Haemostasis. 20 (12): 2964–2971.
  26. ↑ Tan, Yishi; Doyle, Andrew J.; Kumar, Jayant; et al. (2025). "Longitudinal assessment of cerebral infarcts and small vessel disease using magnetic resonance imaging in antiphospholipid syndrome: A single-centre retrospective study". eJHaem. 6 (1). doi: 10.1002/jha2.1065 .
  27. ↑ Chandak, P.; Bennett, D. P.; Phillips, B. L.; et al. (2025). "Real-time organ perfusion monitoring of human kidney transplants using ex vivo normothermic perfusion and reflectance spectroscopy". Royal Society Open Science. 12 (3) 242008. doi: 10.1098/rsos.242008 .
  28. ↑ Thapar, Ankur; Lawton, Rachael; Bradbury, Andrew; et al. (2025). "Compression hosiery to avoid post-thrombotic syndrome: CHAPS randomized clinical trial". British Journal of Surgery. 112 (2).
  29. ↑ Provan, Drew; Stasi, Roberto; Newland, Adrian C.; et al. (2010). "International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168–186. doi:10.1182/blood-2009-06-225565. PMC   6880896 . PMID   19846889.
  30. ↑ Baglin, Trevor; Gray, Erica; Greaves, Malcolm; et al. (2010). "Clinical guidelines for testing for heritable thrombophilia". British Journal of Haematology. 149 (2): 209–220. doi:10.1111/j.1365-2141.2009.08022.x. PMID   20128794.
  31. ↑ Harrison, Claire N.; Bareford, David; Butt, Nauman; et al. (2010). "Guideline for investigation and management of adults and children presenting with a thrombocytosis". British Journal of Haematology. 149 (3): 352–375. doi:10.1111/j.1365-2141.2010.08122.x. PMID   20331485.
  32. ↑ Rossaint, Rolf; Bouillon, Bernd; Cerny, Vladimir; et al. (2010). "Management of bleeding following major trauma: an updated European guideline". Critical Care. 14 (2): R52. doi: 10.1186/cc8943 . PMC   2887168 . PMID   20370902.
  33. ↑ "Venous thromboembolism in adults: reducing the risk in hospital". National Institute for Health and Care Excellence. 2010. Retrieved 26 August 2026.
  34. ↑ "Venous thromboembolic diseases: diagnosis, management and thrombophilia testing". National Institute for Health and Care Excellence. 27 June 2012. Retrieved 26 August 2026.
  35. ↑ "NG191 Managing COVID-19: List of expert advisory panel members and declarations of interest". National Institute for Health and Care Excellence. 2022. Retrieved 26 August 2026.
  36. ↑ Clinical management of COVID-19: living guideline (PDF) (Report). World Health Organization. June 2025. Retrieved 26 August 2026.
  37. ↑ "ISTH 2022 Congress unveils late-breaking abstracts to be presented in London". International Society on Thrombosis and Haemostasis. 27 June 2022. Retrieved 26 August 2026.
  38. ↑ "SSC Subcommittee on Physiological Anticoagulants and Thrombophilia". International Society on Thrombosis and Haemostasis. Retrieved 26 August 2026.
  39. ↑ "Obstetric Haematology". British Society for Haematology. Retrieved 26 August 2026.
  40. ↑ "British Society for Haematology: New BSH Education Committee". Archived from the original on 6 January 2012. Retrieved 30 May 2012.
  41. ↑ "Our Team". PERT Consortium. Retrieved 26 August 2026.
  42. ↑ Hunt, Beverley. "World Thrombosis Day". World Thrombosis Day. Archived from the original on 20 October 2022. Retrieved 20 October 2022.
  43. ↑ "World Thrombosis Day Campaign Appoints Beverley Hunt of London as New Steering Committee Chair". International Society on Thrombosis and Haemostasis. 24 January 2019. Retrieved 26 August 2026.
  44. ↑ "ISTH Council". International Society on Thrombosis and Haemostasis. Retrieved 26 August 2026.
  45. ↑ "2010 Athlone ETU Triathlon European Championships results". World Triathlon. 3 July 2010. Retrieved 26 August 2026.
  46. ↑ "Professor Beverley Hunt, Professor of Haematology, Guy's Hospital in London". BMJ Careers. 18 July 2022. Retrieved 27 August 2026.
  47. ↑ Ball, Philip (2020). "David Hare's fiery account of COVID-19". The Lancet . 396 (10255): 878–879. doi:10.1016/S0140-6736(20)31974-7. PMC   7515584 .
  48. ↑ "Beat the Devil". Bridge Theatre. Retrieved 27 August 2026.
  49. ↑ "King's doctor wins health innovator award". King's College Hospital NHS Foundation Trust. 27 January 2010. Archived from the original on 16 January 2014. Retrieved 18 July 2012.
  50. ↑ "Professor Beverley Hunt awarded OBE in Queen's Birthday Honours". King's College London. June 2019. Retrieved 26 August 2026.
  51. ↑ "No. 62666". The London Gazette (Supplement). 8 June 2019. p. B12.
  52. ↑ "ISTH Presents 2021 Esteemed Career Awards". International Society on Thrombosis and Haemostasis. 2021. Retrieved 26 August 2026.
  53. ↑ "BSH Lifetime Achievement Award Winners". British Society for Haematology.
  54. ↑ "Founders Fund". PERT Consortium.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.